{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T10:52:13Z","timestamp":1788691933348,"version":"build-2803163510"},"reference-count":109,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-13851-1","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T11:30:52Z","timestamp":1763551852000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Oxidation-dependent effects of alpha-1 antitrypsin on wound healing and inflammation"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-6368-5374","authenticated-orcid":false,"given":"Idan","family":"Farber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihie","family":"Sheffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuval","family":"Anav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oron","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dor","family":"Halpern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noam","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya","family":"Darawsha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navit","family":"Ogen-Shtern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabri","family":"El-Saied","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eli C.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eldad","family":"Silberstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"key":"13851_CR1","doi-asserted-by":"publisher","first-page":"1304835","DOI":"10.3389\/fbioe.2023.1304835","volume":"11","author":"Y Dong","year":"2023","unstructured":"Dong, Y. & Wang, Z. ROS-scavenging materials for skin wound healing: advancements and applications. Front. Bioeng. Biotechnol. 11, 1304835 (2023).","journal-title":"Front. Bioeng. Biotechnol."},{"key":"13851_CR2","doi-asserted-by":"crossref","unstructured":"Tavassolifar, M. J., Vodjgani, M., Salehi, Z. & Izad, M. The influence of reactive oxygen species in the immune system and pathogenesis of multiple sclerosis. Autoimmune Dis. 2020 5793817 (2020).","DOI":"10.1155\/2020\/5793817"},{"key":"13851_CR3","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/sj.jidsymp.5650001","volume":"11","author":"U auf dem Keller","year":"2006","unstructured":"auf dem Keller, U., K\u00fcmin, A., Braun, S. & Werner, S. Reactive oxygen species and their detoxification in healing skin wounds. J. Investig Dermatol. Symp. Proc. 11, 106\u2013111 (2006).","journal-title":"J. Investig Dermatol. Symp. Proc."},{"key":"13851_CR4","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1152\/physrev.00040.2012","volume":"94","author":"A Bhattacharyya","year":"2014","unstructured":"Bhattacharyya, A., Chattopadhyay, R., Mitra, S. & Crowe, S. E. Oxidative stress: an essential factor in the pathogenesis of Gastrointestinal mucosal diseases. Physiol. Rev. 94, 329\u2013354 (2014).","journal-title":"Physiol. Rev."},{"key":"13851_CR5","doi-asserted-by":"publisher","first-page":"167","DOI":"10.2147\/CMAR.S188655","volume":"11","author":"J Wei","year":"2019","unstructured":"Wei, J. et al. Radiation-induced skin reactions: mechanism and treatment. Cancer Manag Res. 11, 167\u2013177 (2019).","journal-title":"Cancer Manag Res."},{"key":"13851_CR6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.freeradbiomed.2019.09.018","volume":"149","author":"OT Lyons","year":"2020","unstructured":"Lyons, O. T., Saha, P. & Smith, A. Redox dysregulation in the pathogenesis of chronic venous ulceration. Free Radic Biol. Med. 149, 23\u201329 (2020).","journal-title":"Free Radic Biol. Med."},{"key":"13851_CR7","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1111\/iwj.13192","volume":"16","author":"AE Ferris","year":"2019","unstructured":"Ferris, A. E. & Harding, K. G. An overview of the relationship between anaemia, iron, and venous leg ulcers. Int. Wound J. 16, 1323\u20131329 (2019).","journal-title":"Int. Wound J."},{"key":"13851_CR8","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.freeradbiomed.2018.01.024","volume":"117","author":"S Cadenas","year":"2018","unstructured":"Cadenas, S. ROS and redox signaling in myocardial ischemia-reperfusion injury and cardioprotection. Free Radic Biol. Med. 117, 76\u201389 (2018).","journal-title":"Free Radic Biol. Med."},{"key":"13851_CR9","doi-asserted-by":"publisher","first-page":"101718","DOI":"10.1016\/j.trim.2022.101718","volume":"75","author":"X Su","year":"2022","unstructured":"Su, X. et al. NLRP3 inflammasome: A potential therapeutic target to minimize renal ischemia\/reperfusion injury during transplantation. Transpl. Immunol. 75, 101718 (2022).","journal-title":"Transpl. Immunol."},{"key":"13851_CR10","doi-asserted-by":"publisher","first-page":"103258","DOI":"10.1016\/j.redox.2024.103258","volume":"75","author":"J George","year":"2024","unstructured":"George, J., Lu, Y., Tsuchishima, M. & Tsutsumi, M. Cellular and molecular mechanisms of hepatic ischemia-reperfusion injury: the role of oxidative stress and therapeutic approaches. Redox Biol. 75, 103258 (2024).","journal-title":"Redox Biol."},{"key":"13851_CR11","doi-asserted-by":"publisher","first-page":"3134","DOI":"10.3389\/fimmu.2018.03134","volume":"9","author":"R Monti-Rocha","year":"2018","unstructured":"Monti-Rocha, R. et al. SOCS2 is critical for the balancing of immune response and oxidate stress protecting against Acetaminophen-Induced acute liver injury. Front. Immunol. 9, 3134 (2018).","journal-title":"Front. Immunol."},{"key":"13851_CR12","doi-asserted-by":"crossref","unstructured":"Lopes, F. B., Sarandy, M. M., Novaes, R. D., Valacchi, G. & Gon\u00e7alves, R. V. OxInflammatory responses in the wound healing process: A systematic review. Antioxidants (Basel) 13, (2024).","DOI":"10.3390\/antiox13070823"},{"key":"13851_CR13","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1196\/annals.1427.036","volume":"1147","author":"JA Johnson","year":"2008","unstructured":"Johnson, J. A. et al. The Nrf2-ARE pathway: an indicator and modulator of oxidative stress in neurodegeneration. Ann. N Y Acad. Sci. 1147, 61\u201369 (2008).","journal-title":"Ann. N Y Acad. Sci."},{"key":"13851_CR14","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1152\/physiolgenomics.00066.2016","volume":"48","author":"A Nouvong","year":"2016","unstructured":"Nouvong, A., Ambrus, A. M., Zhang, E. R., Hultman, L. & Coller, H. A. Reactive oxygen species and bacterial biofilms in diabetic wound healing. Physiol. Genomics. 48, 889\u2013896 (2016).","journal-title":"Physiol. Genomics"},{"key":"13851_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/13813455.2015.1115525","volume":"122","author":"T Siddiqui","year":"2016","unstructured":"Siddiqui, T. et al. Reactive oxygen species and anti-proteinases. Arch. Physiol. Biochem. 122, 1\u20137 (2016).","journal-title":"Arch. Physiol. Biochem."},{"key":"13851_CR16","first-page":"97","volume":"54","author":"J Kanta","year":"2011","unstructured":"Kanta, J. The role of hydrogen peroxide and other reactive oxygen species in wound healing. Acta Med. 54, 97\u2013101 (2011).","journal-title":"Acta Med."},{"key":"13851_CR17","doi-asserted-by":"publisher","first-page":"104281","DOI":"10.1016\/j.cellimm.2020.104281","volume":"361","author":"E Ozeri","year":"2021","unstructured":"Ozeri, E. et al. Differential signaling patterns of stimulated bone marrow-derived dendritic cells under \u03b11-antitrypsin-enriched conditions. Cell. Immunol. 361, 104281 (2021).","journal-title":"Cell. Immunol."},{"key":"13851_CR18","first-page":"267","volume":"5","author":"BM Baranovski","year":"2018","unstructured":"Baranovski, B. M. et al. Alpha-1 antitrypsin substitution for extrapulmonary conditions in Alpha-1 antitrypsin deficient patients. Int. J. Chron. Obstruct Pulmon Dis. 5, 267\u2013276 (2018).","journal-title":"Int. J. Chron. Obstruct Pulmon Dis."},{"key":"13851_CR19","doi-asserted-by":"publisher","first-page":"00546","DOI":"10.1183\/23120541.00546-2022","volume":"9","author":"SA Papiris","year":"2023","unstructured":"Papiris, S. A. et al. Diffuse panniculitis in a teenage male with ZZ \u03b1 1 -antitrypsin deficiency. ERJ Open. Res. 9, 00546\u201302022 (2023).","journal-title":"ERJ Open. Res."},{"key":"13851_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.01.074","author":"AN Franciosi","year":"2021","unstructured":"Franciosi, A. N. et al. Alpha-1 antitrypsin deficiency\u2013associated panniculitis. J. Am. Acad. Dermatology Preprint At. https:\/\/doi.org\/10.1016\/j.jaad.2021.01.074 (2021).","journal-title":"J. Am. Acad. Dermatology Preprint At."},{"key":"13851_CR21","doi-asserted-by":"publisher","first-page":"759","DOI":"10.3389\/fimmu.2018.00759","volume":"9","author":"Y Lior","year":"2018","unstructured":"Lior, Y. et al. Point mutation of a Non-Elastase-Binding site in human \u03b11-Antitrypsin alters its Anti-Inflammatory properties. Front. Immunol. 9, 759 (2018).","journal-title":"Front. Immunol."},{"key":"13851_CR22","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1089\/wound.2018.0889","volume":"8","author":"R Schuster","year":"2019","unstructured":"Schuster, R., Bar-Nathan, O., Tiosano, A., Lewis, E. C. & Silberstein, E. Enhanced survival and accelerated perfusion of skin flap to recipient site following administration of human \u03b11-Antitrypsin in murine models. Adv. Wound Care. 8, 281\u2013290 (2019).","journal-title":"Adv. Wound Care"},{"key":"13851_CR23","doi-asserted-by":"publisher","DOI":"10.1089\/wound.2024.0176","author":"D Halpern","year":"2025","unstructured":"Halpern, D. et al. Alpha-1-antitrypsin enhances fat graft survival in a murine model. Adv. Wound Care (New Rochelle). https:\/\/doi.org\/10.1089\/wound.2024.0176 (2025).","journal-title":"Adv. Wound Care (New Rochelle)"},{"key":"13851_CR24","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/cmi.2014.17","volume":"11","author":"A Abecassis","year":"2014","unstructured":"Abecassis, A. et al. \u03b11-antitrypsin increases interleukin-1 receptor antagonist production during pancreatic islet graft transplantation. Cell. Mol. Immunol. 11, 377\u2013386 (2014).","journal-title":"Cell. Mol. Immunol."},{"key":"13851_CR25","doi-asserted-by":"publisher","first-page":"7364","DOI":"10.3390\/ijms23137364","volume":"23","author":"A Gimmon","year":"2022","unstructured":"Gimmon, A. et al. Accelerated wound border closure using a microemulsion containing Non-Inhibitory Recombinant \u03b11-Antitrypsin. Int. J. Mol. Sci. 23, 7364 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"13851_CR26","doi-asserted-by":"publisher","first-page":"113969","DOI":"10.1016\/j.ejmech.2021.113969","volume":"228","author":"Y Lior","year":"2022","unstructured":"Lior, Y., Shtriker, E., Kahremany, S., Lewis, E. C. & Gruzman, A. Development of anti-inflammatory peptidomimetics based on the structure of human alpha1-antitrypsin. Eur. J. Med. Chem. 228, 113969 (2022).","journal-title":"Eur. J. Med. Chem."},{"key":"13851_CR27","doi-asserted-by":"publisher","first-page":"104135","DOI":"10.1016\/j.cellimm.2020.104135","volume":"355","author":"Y Lior","year":"2020","unstructured":"Lior, Y. et al. Application of directed evolution and back-to-consensus algorithms to human alpha1-antitrypsin leads to diminished anti-protease activity and augmented anti-inflammatory activities. Cell. Immunol. 355, 104135 (2020).","journal-title":"Cell. Immunol."},{"key":"13851_CR28","doi-asserted-by":"publisher","first-page":"104177","DOI":"10.1016\/j.cellimm.2020.104177","volume":"356","author":"R Schuster","year":"2020","unstructured":"Schuster, R. et al. Distinct anti-inflammatory properties of alpha1-antitrypsin and corticosteroids reveal unique underlying mechanisms of action. Cell. Immunol. 356, 104177 (2020).","journal-title":"Cell. Immunol."},{"key":"13851_CR29","doi-asserted-by":"crossref","unstructured":"Farber, I. et al. Alpha-1 antitrypsin promotes re-epithelialization by regulating inflammation and migration. Front. Immunol. 16, (2025).","DOI":"10.3389\/fimmu.2025.1586039"},{"key":"13851_CR30","doi-asserted-by":"publisher","first-page":"590","DOI":"10.3389\/fimmu.2019.00590","volume":"10","author":"Z Kaner","year":"2019","unstructured":"Kaner, Z. et al. S-nitrosylation of \u03b11-antitrypsin triggers macrophages toward inflammatory phenotype and enhances intra-cellular bacteria elimination. Front. Immunol. 10, 590 (2019).","journal-title":"Front. Immunol."},{"key":"13851_CR31","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1093\/infdis\/jiu620","volume":"211","author":"Z Kaner","year":"2015","unstructured":"Kaner, Z. et al. Acute phase protein \u03b11-antitrypsin reduces the bacterial burden in mice by selective modulation of innate cell responses. J. Infect. Dis. 211, 1489\u20131498 (2015).","journal-title":"J. Infect. Dis."},{"key":"13851_CR32","first-page":"2041","volume":"79","author":"H Carp","year":"1982","unstructured":"Carp, H., Miller, F., HOIDALT, J. R. & Janoff, A. Potential mechanism of emphysema: a1-Proteinase inhibitor recovered from lungs of cigarette smokers contains oxidized methionine and has decreased elastase inhibitory capacity (oxidant\/obstructive lung Disease\/leukocyte). Med. Sci. 79, 2041\u20132045 (1982).","journal-title":"Med. Sci."},{"key":"13851_CR33","first-page":"277","volume":"5","author":"FA V\u00e9zina","year":"2018","unstructured":"V\u00e9zina, F. A. & Cantin, A. M. Antioxidants and chronic obstructive pulmonary disease. Int. J. Chron. Obstruct Pulmon Dis. 5, 277\u2013288 (2018).","journal-title":"Int. J. Chron. Obstruct Pulmon Dis."},{"key":"13851_CR34","doi-asserted-by":"publisher","first-page":"27258","DOI":"10.1016\/S0021-9258(19)61505-X","volume":"275","author":"C Taggart","year":"2000","unstructured":"Taggart, C. et al. Oxidation of either methionine 351 or methionine 358 in \u03b11-antitrypsin causes loss of anti-neutrophil elastase activity. J. Biol. Chem. 275, 27258\u201327265 (2000).","journal-title":"J. Biol. Chem."},{"key":"13851_CR35","doi-asserted-by":"publisher","unstructured":"Janciauskiene, S. The beneficial effects of antioxidants in health and diseases. Chron.  Obstruct.  Pulmon.  Dis. 7 182\u2013202. https:\/\/doi.org\/10.15326\/jcopdf.7.3.2019.0152 (2020).","DOI":"10.15326\/jcopdf.7.3.2019.0152"},{"key":"13851_CR36","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1056\/NEJMra1910234","volume":"382","author":"P Strnad","year":"2020","unstructured":"Strnad, P., McElvaney, N. G. & Lomas, D. A. Alpha1-Antitrypsin deficiency. N Engl. J. Med. 382, 1443\u20131455 (2020).","journal-title":"N Engl. J. Med."},{"key":"13851_CR37","doi-asserted-by":"publisher","unstructured":"Lechowicz, U., Rudzinski, S., Jezela-Stanek, A., Janciauskiene, S. & Chorostowska-Wynimko, J. Post-translational modifications of circulating alpha-1-antitrypsin protein. Int. J.  Mol.  Sci. 21 1\u201318.  https:\/\/doi.org\/10.3390\/ijms21239187 (2020).","DOI":"10.3390\/ijms21239187"},{"key":"13851_CR38","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.biocel.2007.07.016","volume":"40","author":"D Subramaniyam","year":"2008","unstructured":"Subramaniyam, D. et al. TNF-\u03b1-induced self expression in human lung endothelial cells is inhibited by native and oxidized \u03b11-antitrypsin. Int. J. Biochem. Cell. Biol. 40, 258\u2013271 (2008).","journal-title":"Int. J. Biochem. Cell. Biol."},{"key":"13851_CR39","first-page":"1","volume":"3","author":"E Lewis","year":"2017","unstructured":"Lewis, E. a1-Antitrypsin therapy for Non-Deficient individuals: integrating and mitigating Cross-Pathology inflammatory and immune responses to the injured cell. Intern. Med. Rev. 3, 1\u201328 (2017).","journal-title":"Intern. Med. Rev."},{"key":"13851_CR40","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s001090050364","volume":"77","author":"R Dhami","year":"1999","unstructured":"Dhami, R. et al. Pulmonary epithelial expression of human alpha1-antitrypsin in Transgenic mice results in delivery of alpha1-antitrypsin protein to the interstitium. J. Mol. Med. 77, 377\u2013385 (1999).","journal-title":"J. Mol. Med."},{"key":"13851_CR41","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3109\/2000656X.2012.731000","volume":"47","author":"T Tsumano","year":"2013","unstructured":"Tsumano, T. et al. A new mouse model of impaired wound healing after irradiation. J. Plast. Surg. Hand Surg. 47, 83\u201388 (2013).","journal-title":"J. Plast. Surg. Hand Surg."},{"key":"13851_CR42","doi-asserted-by":"publisher","first-page":"3992","DOI":"10.1002\/pmic.200601032","volume":"7","author":"O Guipaud","year":"2007","unstructured":"Guipaud, O. et al. Time-course analysis of mouse serum proteome changes following exposure of the skin to ionizing radiation. Proteomics 7, 3992\u20134002 (2007).","journal-title":"Proteomics"},{"key":"13851_CR43","doi-asserted-by":"publisher","DOI":"10.1097\/GOX.0000000000003006","author":"J Kuhn","year":"2020","unstructured":"Kuhn, J. et al. Nrf2-activating therapy accelerates wound healing in a model of cutaneous chronic venous insufficiency. Plast. Reconstr. Surg. - Global Open. https:\/\/doi.org\/10.1097\/GOX.0000000000003006 (2020).","journal-title":"Plast. Reconstr. Surg. - Global Open."},{"key":"13851_CR44","doi-asserted-by":"publisher","first-page":"7198","DOI":"10.1128\/MCB.23.20.7198-7209.2003","volume":"23","author":"SB Cullinan","year":"2003","unstructured":"Cullinan, S. B. et al. Nrf2 is a direct PERK substrate and effector of PERK-dependent cell survival. Mol. Cell. Biol. 23, 7198\u20137209 (2003).","journal-title":"Mol. Cell. Biol."},{"key":"13851_CR45","first-page":"130","volume":"3","author":"RA Stockley","year":"2015","unstructured":"Stockley, R. A. The multiple facets of alpha-1-antitrypsin. Ann. Transl Med. 3, 130 (2015).","journal-title":"Ann. Transl Med."},{"key":"13851_CR46","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.1016\/j.transproceed.2019.04.084","volume":"51","author":"KH Jeong","year":"2019","unstructured":"Jeong, K. H. et al. Protective effect of alpha 1-Antitrypsin on renal Ischemia-Reperfusion injury. Transpl. Proc. 51, 2814\u20132822 (2019).","journal-title":"Transpl. Proc."},{"key":"13851_CR47","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/S0022-3565(24)38988-8","volume":"295","author":"N Ikebe","year":"2000","unstructured":"Ikebe, N. et al. Protective effect of S-nitrosylated alpha(1)-protease inhibitor on hepatic ischemia-reperfusion injury. J. Pharmacol. Exp. Ther. 295, 904\u2013911 (2000).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"13851_CR48","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jss.2024.04.023","volume":"299","author":"I Jochmans","year":"2024","unstructured":"Jochmans, I., Lerut, E., Monbaliu, D. & Pirenne, J. Impact of a single dose of Alpha-1-Antitrypsin in a rat model of bilateral kidney ischemia reperfusion injury. J. Surg. Res. 299, 179\u2013187 (2024).","journal-title":"J. Surg. Res."},{"key":"13851_CR49","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s13311-022-01203-0","volume":"19","author":"A Simats","year":"2022","unstructured":"Simats, A. et al. Ceruletide and alpha-1 antitrypsin as a novel combination therapy for ischemic stroke. Neurotherapeutics 19, 513\u2013527 (2022).","journal-title":"Neurotherapeutics"},{"key":"13851_CR50","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.healun.2017.09.019","volume":"37","author":"H Lin","year":"2018","unstructured":"Lin, H. et al. \u03b11-Anti-trypsin improves function of Porcine donor lungs during ex-vivo lung perfusion. J. Heart Lung Transpl. 37, 656\u2013666 (2018).","journal-title":"J. Heart Lung Transpl."},{"key":"13851_CR51","doi-asserted-by":"publisher","first-page":"e0168981","DOI":"10.1371\/journal.pone.0168981","volume":"12","author":"N Maicas","year":"2017","unstructured":"Maicas, N. et al. Human Alpha-1-Antitrypsin (hAAT) therapy reduces renal dysfunction and acute tubular necrosis in a murine model of bilateral kidney ischemia-reperfusion injury. PLoS One. 12, e0168981 (2017).","journal-title":"PLoS One"},{"key":"13851_CR52","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.healun.2013.10.031","volume":"33","author":"W Gao","year":"2014","unstructured":"Gao, W. et al. \u03b11-Antitrypsin inhibits ischemia reperfusion-induced lung injury by reducing inflammatory response and cell death. J. Heart Lung Transpl. 33, 309\u2013315 (2014).","journal-title":"J. Heart Lung Transpl."},{"key":"13851_CR53","doi-asserted-by":"publisher","first-page":"176","DOI":"10.3389\/fphys.2016.00176","volume":"7","author":"Y Feng","year":"2016","unstructured":"Feng, Y. et al. Alpha-1 antitrypsin prevents the development of preeclampsia through suppression of oxidative stress. Front. Physiol. 7, 176 (2016).","journal-title":"Front. Physiol."},{"key":"13851_CR54","doi-asserted-by":"crossref","unstructured":"Sosulski, M. L. et al. Gene therapy for alpha 1-antitrypsin deficiency with an oxidant-resistant human alpha 1-antitrypsin. JCI Insight 5, (2020).","DOI":"10.1172\/jci.insight.135951"},{"key":"13851_CR55","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/0014-5793(89)80725-2","volume":"250","author":"KL Maier","year":"1989","unstructured":"Maier, K. L. et al. Different selectivities of oxidants during oxidation of methionine residues in the alpha-1-proteinase inhibitor. FEBS Lett. 250, 221\u2013226 (1989).","journal-title":"FEBS Lett."},{"key":"13851_CR56","doi-asserted-by":"publisher","first-page":"104528","DOI":"10.1016\/j.cellimm.2022.104528","volume":"375","author":"L Segal","year":"2022","unstructured":"Segal, L. & Lewis, E. C. The lipid ties of \u03b11-antitrypsin: structural and functional aspects. Cell. Immunol. 375, 104528 (2022).","journal-title":"Cell. Immunol."},{"key":"13851_CR57","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.3390\/ijms23052441","volume":"23","author":"ME O\u2019Brien","year":"2022","unstructured":"O\u2019Brien, M. E. et al. A review of alpha-1 antitrypsin binding partners for immune regulation and potential therapeutic application. Int. J. Mol. Sci. 23, 2441 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"13851_CR58","doi-asserted-by":"publisher","first-page":"6245","DOI":"10.1021\/bi025599p","volume":"41","author":"SW Griffiths","year":"2002","unstructured":"Griffiths, S. W. & Cooney, C. L. Relationship between protein structure and methionine oxidation in Recombinant human alpha 1-antitrypsin. Biochemistry 41, 6245\u20136252 (2002).","journal-title":"Biochemistry"},{"key":"13851_CR59","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1515\/BC.1999.153","volume":"380","author":"M Rapala-Kozik","year":"1999","unstructured":"Rapala-Kozik, M., Potempa, J., Nelson, D., Kozik, A. & Travis, J. Comparative cleavage sites within the reactive-site loop of native and oxidized alpha1-proteinase inhibitor by selected bacterial proteinases. Biol. Chem. 380, 1211\u20131216 (1999).","journal-title":"Biol. Chem."},{"key":"13851_CR60","doi-asserted-by":"publisher","first-page":"25486","DOI":"10.1074\/jbc.M203089200","volume":"277","author":"SW Griffiths","year":"2002","unstructured":"Griffiths, S. W., King, J. & Cooney, C. L. The reactivity and oxidation pathway of cysteine 232 in Recombinant human alpha 1-antitrypsin. J. Biol. Chem. 277, 25486\u201325492 (2002).","journal-title":"J. Biol. Chem."},{"key":"13851_CR61","doi-asserted-by":"publisher","first-page":"102060","DOI":"10.1016\/j.redox.2021.102060","volume":"46","author":"K Madyaningrana","year":"2021","unstructured":"Madyaningrana, K. et al. Alpha1-antitrypsin counteracts heme-induced endothelial cell inflammatory activation, autophagy dysfunction and death. Redox Biol. 46, 102060 (2021).","journal-title":"Redox Biol."},{"key":"13851_CR62","doi-asserted-by":"publisher","first-page":"3751","DOI":"10.2147\/OTT.S242579","volume":"13","author":"DM Wu","year":"2020","unstructured":"Wu, D. M. et al. Alpha-1 antitrypsin induces Epithelial-to-Mesenchymal transition, Endothelial-to-Mesenchymal transition, and drug resistance in lung cancer cells. Onco Targets Ther. 13, 3751\u20133763 (2020).","journal-title":"Onco Targets Ther."},{"issue":"Suppl 2","key":"13851_CR63","first-page":"S146","volume":"13","author":"KA Serban","year":"2016","unstructured":"Serban, K. A. & Petrache, I. Alpha-1 antitrypsin and lung cell apoptosis. Ann. Am. Thorac. Soc. 13 (Suppl 2), S146\u2013S149 (2016).","journal-title":"Ann. Am. Thorac. Soc."},{"key":"13851_CR64","doi-asserted-by":"crossref","unstructured":"Feng, Y. et al. Cytoprotective role of alpha-1 antitrypsin in vascular endothelial cell under hypoxia\/reoxygenation condition. (2015).","DOI":"10.1097\/FJC.0000000000000250"},{"key":"13851_CR65","doi-asserted-by":"publisher","first-page":"113002","DOI":"10.18632\/oncotarget.22949","volume":"8","author":"Y Feng","year":"2017","unstructured":"Feng, Y. et al. Alpha-1-antitrypsin functions as a protective factor in preeclampsia through activating Smad2 and inhibitor of DNA binding 4. Oncotarget 8, 113002\u2013113012 (2017).","journal-title":"Oncotarget"},{"key":"13851_CR66","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.3727\/096368912X657701","volume":"22","author":"K Bellacen","year":"2013","unstructured":"Bellacen, K., Kalay, N., Ozeri, E., Shahaf, G. & Lewis, E. C. Revascularization of pancreatic islet allografts is enhanced by \u03b1-1-antitrypsin under anti-inflammatory conditions. Cell. Transpl. 22, 2119\u20132133 (2013).","journal-title":"Cell. Transpl."},{"key":"13851_CR67","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1042\/bj3420481","volume":"342 Pt 3","author":"Y Morel","year":"1999","unstructured":"Morel, Y. & Barouki, R. Repression of gene expression by oxidative stress. Biochem. J. 342 Pt 3, 481\u2013496 (1999).","journal-title":"Biochem. J."},{"key":"13851_CR68","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1093\/jleuko\/qiac004","volume":"113","author":"K Sivaraman","year":"2023","unstructured":"Sivaraman, K. et al. Mice inflammatory responses to inhaled aerosolized LPS: effects of various forms of human alpha1-antitrypsin. J. Leukoc. Biol. 113, 58\u201370 (2023).","journal-title":"J. Leukoc. Biol."},{"key":"13851_CR69","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/cr.2010.178","volume":"21","author":"MJ Morgan","year":"2011","unstructured":"Morgan, M. J. & Liu, Z. G. Crosstalk of reactive oxygen species and NF-\u03baB signaling. Cell. Res. 21, 103\u2013115 (2011).","journal-title":"Cell. Res."},{"key":"13851_CR70","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/j.bcp.2006.04.011","volume":"72","author":"G Gloire","year":"2006","unstructured":"Gloire, G., Legrand-Poels, S. & Piette, J. NF-kappaB activation by reactive oxygen species: fifteen years later. Biochem. Pharmacol. 72, 1493\u20131505 (2006).","journal-title":"Biochem. Pharmacol."},{"key":"13851_CR71","doi-asserted-by":"crossref","unstructured":"Yuan, Y. et al. Anti-inflammaging effects of human alpha-1 antitrypsin. Aging Cell 17, (2018).","DOI":"10.1111\/acel.12694"},{"key":"13851_CR72","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S2213-2600(15)00094-6","volume":"3","author":"RA Stockley","year":"2015","unstructured":"Stockley, R. A. \u03b11-antitrypsin: a polyfunctional protein? Lancet Respir Med. 3, 341\u2013343 (2015).","journal-title":"Lancet Respir Med."},{"key":"13851_CR73","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1097\/MAO.0000000000004231","volume":"45","author":"S El-Saied","year":"2024","unstructured":"El-Saied, S. et al. Trauma-Induced vestibular dysfunction: improved repair under local treatment with \u03b11-Antitrypsin. Otol Neurotol. 45, 818\u2013823 (2024).","journal-title":"Otol Neurotol"},{"key":"13851_CR74","doi-asserted-by":"publisher","first-page":"217ra1","DOI":"10.1126\/scitranslmed.3007116","volume":"6","author":"DA Bergin","year":"2014","unstructured":"Bergin, D. A. et al. The Circulating proteinase inhibitor \u03b1-1 antitrypsin regulates neutrophil degranulation and autoimmunity. Sci. Transl Med. 6, 217ra1 (2014).","journal-title":"Sci. Transl Med."},{"key":"13851_CR75","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.bbrc.2004.06.123","volume":"321","author":"S Janciauskiene","year":"2004","unstructured":"Janciauskiene, S. et al. Inhibition of lipopolysaccharide-mediated human monocyte activation, in vitro, by alpha1-antitrypsin. Biochem. Biophys. Res. Commun. 321, 592\u2013600 (2004).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"13851_CR76","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1165\/rcmb.2010-0328OC","volume":"45","author":"S Alam","year":"2011","unstructured":"Alam, S., Li, Z., Janciauskiene, S. & Mahadeva, R. Oxidation of Z \u03b11-antitrypsin by cigarette smoke induces polymerization: a novel mechanism of early-onset emphysema. Am. J. Respir Cell. Mol. Biol. 45, 261\u2013269 (2011).","journal-title":"Am. J. Respir Cell. Mol. Biol."},{"key":"13851_CR77","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1002\/hep.27024","volume":"59","author":"N Jedicke","year":"2014","unstructured":"Jedicke, N. et al. \u03b1-1-antitrypsin inhibits acute liver failure in mice. Hepatology 59, 2299\u20132308 (2014).","journal-title":"Hepatology"},{"key":"13851_CR78","doi-asserted-by":"publisher","first-page":"25258","DOI":"10.1038\/s41598-024-75786-3","volume":"14","author":"M Barakat","year":"2024","unstructured":"Barakat, M. et al. Non-electrophilic NRF2 activators promote wound healing in human keratinocytes and diabetic mice and demonstrate selective downstream gene targeting. Sci. Rep. 14, 25258 (2024).","journal-title":"Sci. Rep."},{"key":"13851_CR79","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1111\/j.1600-0609.2011.01601.x","volume":"86","author":"SN Clemmensen","year":"2011","unstructured":"Clemmensen, S. N. et al. Alpha-1-antitrypsin is produced by human neutrophil granulocytes and their precursors and liberated during granule exocytosis. Eur. J. Haematol. 86, 517\u2013530 (2011).","journal-title":"Eur. J. Haematol."},{"key":"13851_CR80","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s11011-011-9239-9","volume":"26","author":"S Subramanian","year":"2011","unstructured":"Subramanian, S. et al. Sustained expression of Circulating human alpha-1 antitrypsin reduces inflammation, increases CD4\u2009+\u2009FoxP3\u2009+\u2009Treg cell population and prevents signs of experimental autoimmune encephalomyelitis in mice. Metab. Brain Dis. 26, 107\u2013113 (2011).","journal-title":"Metab. Brain Dis."},{"key":"13851_CR81","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1111\/imm.12149","volume":"140","author":"M Mizrahi","year":"2013","unstructured":"Mizrahi, M. et al. Human \u03b11-antitrypsin modifies B-lymphocyte responses during allograft transplantation. Immunology 140, 362\u2013373 (2013).","journal-title":"Immunology"},{"key":"13851_CR82","doi-asserted-by":"publisher","first-page":"00537","DOI":"10.1183\/23120541.00537-2024","volume":"11","author":"M Brantly","year":"2025","unstructured":"Brantly, M. et al. Inhaled alpha-1 antitrypsin (AAT) restores lower respiratory tract protease-antiprotease homoeostasis and reduces inflammation in AAT-deficient individuals: a randomised phase 2 study. ERJ Open. Res. 11, 00537\u201302024 (2025).","journal-title":"ERJ Open. Res."},{"key":"13851_CR83","first-page":"L593","volume":"266","author":"MD Evans","year":"1994","unstructured":"Evans, M. D. & Pryor, W. A. Cigarette smoking, emphysema, and damage to alpha 1-proteinase inhibitor. Am. J. Physiol. 266, L593\u2013611 (1994).","journal-title":"Am. J. Physiol."},{"key":"13851_CR84","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1080\/02841860310014732","volume":"42","author":"H Strander","year":"2003","unstructured":"Strander, H., Turesson, I. & Cavallin-St\u00e5hl, E. A systematic overview of radiation therapy effects in soft tissue sarcomas. Acta Oncol. 42, 516\u2013531 (2003).","journal-title":"Acta Oncol."},{"key":"13851_CR85","doi-asserted-by":"publisher","DOI":"10.1111\/odi.14999","author":"R Abdalla-Aslan","year":"2024","unstructured":"Abdalla-Aslan, R., Keegan, R., Zadik, Y., Yarom, N. & Elad, S. Recent advances in cancer therapy-associated oral mucositis. Oral Dis. https:\/\/doi.org\/10.1111\/odi.14999 (2024).","journal-title":"Oral Dis."},{"key":"13851_CR86","doi-asserted-by":"publisher","first-page":"510","DOI":"10.12968\/jowc.2022.31.6.510","volume":"31","author":"J Azar","year":"2022","unstructured":"Azar, J., Rao, A. & Oropallo, A. Chronic venous insufficiency: a comprehensive review of management. J. Wound Care. 31, 510\u2013519 (2022).","journal-title":"J. Wound Care"},{"key":"13851_CR87","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1203\/PDR.0b013e31822a357e","volume":"70","author":"C Karaaslan","year":"2011","unstructured":"Karaaslan, C. et al. Elastase inhibitory activity of airway \u03b11-antitrypsin is protected by treatment with a catalytic antioxidant in a baboon model of severe bronchopulmonary dysplasia. Pediatr. Res. 70, 363\u2013367 (2011).","journal-title":"Pediatr. Res."},{"key":"13851_CR88","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/312077a0","volume":"312","author":"S Rosenberg","year":"1984","unstructured":"Rosenberg, S., Barr, P. J., Najarian, R. C. & Hallewell, R. A. Synthesis in yeast of a functional oxidation-resistant mutant of human alpha-antitrypsin. Nature 312, 77\u201380 (1984).","journal-title":"Nature"},{"key":"13851_CR89","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.freeradbiomed.2018.03.015","volume":"120","author":"DZ Silberstein","year":"2018","unstructured":"Silberstein, D. Z. et al. An oxidation-resistant, Recombinant alpha-1 antitrypsin produced in Nicotiana benthamiana. Free Radic Biol. Med. 120, 303\u2013310 (2018).","journal-title":"Free Radic Biol. Med."},{"key":"13851_CR90","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1089\/hum.2022.192","volume":"34","author":"JB Rosenberg","year":"2023","unstructured":"Rosenberg, J. B. et al. Safety of intravenous administration of an AAV8 vector coding for an Oxidation-Resistant human \u03b11-Antitrypsin for the treatment of \u03b11-Antitrypsin deficiency. Hum. Gene Ther. 34, 139\u2013149 (2023).","journal-title":"Hum. Gene Ther."},{"key":"13851_CR91","doi-asserted-by":"publisher","first-page":"13533","DOI":"10.3390\/ijms241713533","volume":"24","author":"M D\u2019Amato","year":"2023","unstructured":"D\u2019Amato, M. et al. Could the oxidation of \u03b11-antitrypsin prevent the binding of human neutrophil elastase in COVID-19 patients? Int. J. Mol. Sci. 24, 13533 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"13851_CR92","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/molehr\/gan071","volume":"15","author":"N Izumi-Yoneda","year":"2009","unstructured":"Izumi-Yoneda, N. et al. Alpha 1 antitrypsin activity is decreased in human Amnion in premature rupture of the fetal membranes. Mol. Hum. Reprod. 15, 49\u201357 (2009).","journal-title":"Mol. Hum. Reprod."},{"key":"13851_CR93","doi-asserted-by":"publisher","first-page":"934","DOI":"10.3109\/14767058.2011.600369","volume":"25","author":"J Baron","year":"2012","unstructured":"Baron, J. et al. \u03911-antitrypsin insufficiency is a possible contributor to preterm premature rupture of membranes. J. Matern Fetal Neonatal Med. 25, 934\u2013937 (2012).","journal-title":"J. Matern Fetal Neonatal Med."},{"key":"13851_CR94","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0009-8981(01)00765-3","volume":"317","author":"M Ueda","year":"2002","unstructured":"Ueda, M., Mashiba, S. & Uchida, K. Evaluation of oxidized alpha-1-antitrypsin in blood as an oxidative stress marker using anti-oxidative alpha1-AT monoclonal antibody. Clin. Chim. Acta. 317, 125\u2013131 (2002).","journal-title":"Clin. Chim. Acta"},{"key":"13851_CR95","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1136\/ard.50.12.915","volume":"50","author":"K Chidwick","year":"1991","unstructured":"Chidwick, K., Winyard, P. G., Zhang, Z., Farrell, A. J. & Blake, D. R. Inactivation of the elastase inhibitory activity of alpha 1 antitrypsin in fresh samples of synovial fluid from patients with rheumatoid arthritis. Ann. Rheum. Dis. 50, 915\u2013916 (1991).","journal-title":"Ann. Rheum. Dis."},{"key":"13851_CR96","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/BF01489487","volume":"15","author":"R Sepper","year":"1995","unstructured":"Sepper, R., Konttinen, Y. T., Ingman, T. & Sorsa, T. Presence, activities, and molecular forms of cathepsin G, elastase, alpha 1-antitrypsin, and alpha 1-antichymotrypsin in bronchiectasis. J. Clin. Immunol. 15, 27\u201334 (1995).","journal-title":"J. Clin. Immunol."},{"key":"13851_CR97","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.ejheart.2008.01.016","volume":"10","author":"C Banfi","year":"2008","unstructured":"Banfi, C. et al. Oxidized proteins in plasma of patients with heart failure: role in endothelial damage. Eur. J. Heart Fail. 10, 244\u2013251 (2008).","journal-title":"Eur. J. Heart Fail."},{"key":"13851_CR98","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s13277-012-0597-7","volume":"34","author":"W Jamnongkan","year":"2013","unstructured":"Jamnongkan, W. et al. Oxidized alpha-1 antitrypsin as a predictive risk marker of opisthorchiasis-associated cholangiocarcinoma. Tumour Biol. 34, 695\u2013704 (2013).","journal-title":"Tumour Biol."},{"key":"13851_CR99","doi-asserted-by":"publisher","first-page":"e202115241","DOI":"10.1002\/anie.202115241","volume":"61","author":"C Dong","year":"2022","unstructured":"Dong, C. et al. Site-specific conjugation of a selenopolypeptide to alpha-1-antitrypsin enhances oxidation resistance and Pharmacological properties. Angew Chem. Int. Ed. Engl. 61, e202115241 (2022).","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"13851_CR100","doi-asserted-by":"publisher","first-page":"1225748","DOI":"10.3389\/fimmu.2023.1225748","volume":"14","author":"S Farhan","year":"2023","unstructured":"Farhan, S. & Holtan, S. G. Graft-versus-host disease: teaching old drugs new tricks at less cost. Front. Immunol. 14, 1225748 (2023).","journal-title":"Front. Immunol."},{"key":"13851_CR101","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1042\/BST20230078","volume":"51","author":"X Bai","year":"2023","unstructured":"Bai, X. et al. Alpha-1-antitrypsin antagonizes COVID-19: a review of the epidemiology, molecular mechanisms, and clinical evidence. Biochem. Soc. Trans. 51, 1361\u20131375 (2023).","journal-title":"Biochem. Soc. Trans."},{"key":"13851_CR102","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.cca.2022.07.005","volume":"534","author":"X Zhang","year":"2022","unstructured":"Zhang, X., Ostrov, D. A. & Tian, H. Alpha-1 antitrypsin: A novel biomarker and potential therapeutic approach for metabolic diseases. Clin. Chim. Acta. 534, 71\u201376 (2022).","journal-title":"Clin. Chim. Acta"},{"key":"13851_CR103","doi-asserted-by":"publisher","first-page":"109001","DOI":"10.1016\/j.intimp.2022.109001","volume":"110","author":"R Sun","year":"2022","unstructured":"Sun, R. et al. Alpha-1 antitrypsin in autoimmune diseases: roles and therapeutic prospects. Int. Immunopharmacol. 110, 109001 (2022).","journal-title":"Int. Immunopharmacol."},{"key":"13851_CR104","doi-asserted-by":"publisher","first-page":"963689724124301","DOI":"10.1177\/09636897241243014","volume":"33","author":"H Wang","year":"2024","unstructured":"Wang, H. et al. Alpha-1 antitrypsin augmentation therapy in chronic pancreatitis patients undergoing total pancreatectomy and islet autotransplantation: A randomized, controlled study. Cell. Transpl. 33, 9636897241243014 (2024).","journal-title":"Cell. Transpl."},{"key":"13851_CR105","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.medj.2022.03.001","volume":"3","author":"OJ McElvaney","year":"2022","unstructured":"McElvaney, O. J. et al. A randomized, double-blind, placebo-controlled trial of intravenous alpha-1 antitrypsin for ARDS secondary to COVID-19. Med 3, 233\u2013248e6 (2022).","journal-title":"Med"},{"key":"13851_CR106","doi-asserted-by":"crossref","unstructured":"Lebenthal, Y. et al. A phase II, double-blind, randomized, placebo-controlled, multicenter study evaluating the efficacy and safety of alpha-1 antitrypsin (AAT) (Glassia\u00ae) in the treatment of recent-onset type 1 diabetes. Int. J. Mol. Sci. 20 (2019).","DOI":"10.3390\/ijms20236032"},{"key":"13851_CR107","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.2217\/imt-2018-0047","volume":"10","author":"A Brener","year":"2018","unstructured":"Brener, A. et al. Long-term safety of \u03b1-1 antitrypsin therapy in children and adolescents with type 1 diabetes. Immunotherapy 10, 1137\u20131148 (2018).","journal-title":"Immunotherapy"},{"key":"13851_CR108","first-page":"282","volume":"11","author":"ML Brantly","year":"2024","unstructured":"Brantly, M. L. et al. Recombinant Alpha-1 antitrypsin-Fc fusion protein INBRX-101 in adults with Alpha-1 antitrypsin deficiency: A phase 1 study. Int. J. Chron. Obstruct Pulmon Dis. 11, 282\u2013292 (2024).","journal-title":"Int. J. Chron. Obstruct Pulmon Dis."},{"key":"13851_CR109","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s12931-021-01784-y","volume":"22","author":"K Takeda","year":"2021","unstructured":"Takeda, K., Kim, S. H., Joetham, A., Petrache, I. & Gelfand, E. W. Therapeutic benefits of Recombinant alpha1-antitrypsin IgG1 Fc-fusion protein in experimental emphysema. Respir Res. 22, 207 (2021).","journal-title":"Respir Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-13851-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-13851-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-13851-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T13:03:32Z","timestamp":1763557412000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-13851-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,19]]},"references-count":109,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["13851"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-13851-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,19]]},"assertion":[{"value":"12 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study is reported in accordance with ARRIVE guidelines. Animal: Studies were approved by the Institutional Animal Care and Use Committee (IL-155-10-2022D) and conducted in line with the Guide for the Care and Use of Laboratory Animals, 8th Edition.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"All authors have read and agreed to the published version of the manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"40673"}}